Status:
ACTIVE_NOT_RECRUITING
Pathophysiology and Risk of Atrial Fibrillation Detected After Ischemic Stroke
Lead Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Collaborating Sponsors:
Western University, Canada
London Health Sciences Centre
Conditions:
Stroke, Ischemic
Transient Ischemic Attack
Eligibility:
All Genders
18+ years
Brief Summary
This prospective non-interventional cohort study investigates the pathophysiology of Atrial Fibrillation Detected After Stroke or transient ischemic attack (AFDAS) by comparing the autonomic function ...
Detailed Description
This study enrolls patients with acute ischemic stroke at the London Health Sciences Center in London, Ontario, Canada. The heart rhythm of the patients is monitored with a CardioSTAT® Holter device (...
Eligibility Criteria
Inclusion
- MCA territory-transient ischemic attack or -acute ischemic stroke patients seen in the Emergency Department or admitted to University Hospital, London, Ontario, Canada
- Age ≥ 18 years old
- Patient or Substitute Decision Maker must give written informed consent
Exclusion
- Patients with autonomic dysfunction such as Parkinson's disease that can be interfering with outcome assessment based on qualified investigator's judgment.
- Patients taking tricyclic antidepressant (TCAs)
- Patients in whom the acute stroke is primarily hemorrhagic
- Patients with both TIA and atrial fibrillation
- Patients with both TIA and large vessel disease
- Patients with inflammatory diseases
Key Trial Info
Start Date :
April 18 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 7 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03275155
Start Date
April 18 2017
End Date
May 7 2026
Last Update
April 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital, London Helath Sciences Center
London, Ontario, Canada, N6A 5A5